The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Teva Pharmaceutical Industries Ltd
TASE:TEVA
|
IL |
|
Labcorp Holdings Inc
F:N6B
|
US |
|
Kongsberg Gruppen ASA
F:KOZ1
|
NO |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
L
|
Likewise Group PLC
F:7RL
|
UK |
|
ZincX Resources Corp
XTSX:ZNX
|
CA |
|
Takasago Thermal Engineering Co Ltd
F:Q74
|
JP |
|
B
|
Baxter International Inc
XMUN:BTL
|
US |
|
C
|
China Resources Land Ltd
XMUN:CHZ
|
HK |
|
M
|
Macrogen Inc
KOSDAQ:038290
|
KR |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
Capital One Financial Corp
NYSE:COF
|
US |
|
F
|
FACC AG
F:1FC
|
AT |
|
V
|
Valiant Gold Ltd
OTC:VOYRF
|
AU |
|
D
|
DMCI Holdings Inc
XPHS:DMC
|
PH |
|
Cimpress PLC
NASDAQ:CMPR
|
IE |
|
N
|
N2Tech Co Ltd
KOSDAQ:227950
|
KR |
|
F
|
Friwo AG
XHAM:CEA
|
DE |
|
M
|
Molson Coors Beverage Co
LSE:0K2K
|
US |
|
M
|
Marriott International Inc
DUS:MAQ
|
US |
|
Addus Homecare Corp
NASDAQ:ADUS
|
US |
|
Montana Aerospace AG
OTC:MTASF
|
CH |
|
Silex Systems Ltd
OTC:SILXY
|
AU |
|
Jungheinrich AG
XETRA:JUN3
|
DE |
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
TEVA does not have any price targets made by Wall Street professionals.
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -1%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 8 years is 7%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 61%.
Over the last 13 years, the compound annual growth rate for Net Income has been -3%. The projected CAGR for the next 8 years is 20%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more